KIMBERLY BROWN-GROSS: Open Payments
NPI 1124781356 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 10 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $111 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| ABBVIE INC. | 1 | $29 |
Products named: TRINTELLIX, ABILIFY MAINTENA, AUSTEDO XR, REXULTI, VRAYLAR.
Industry payments across MD — which companies pay providers there.
